AlphaYouKC
Insider selling
Kyle Carver sold $415K of Evommune, Inc. (EVMN) stock
Kyle Carver, Chief Financial Officer of Evommune, Inc. (EVMN), sold 18,175 shares of EVMN stock worth $415K, per an SEC Form 4 filed Jun 1, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 28, 2026, 4 days before it was made public.
EVMN has moved -59.5% since the trade date, from $23.33 to $9.45 (Sep 21, 2026 close).
- Traded
- May 28, 2026
- Disclosed
- Jun 1, 2026
- Filing delay
- 4 days
- Price since
- -59.5%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More EVMN insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.